Core Elements for Implementing Antimicrobial Stewardship Programs in Korean General Hospitals

Currently, antimicrobial resistance (AMR) is a major threat to global public health. The antimicrobial stewardship program (ASP) has been proposed as an important approach to overcome this crisis. ASP supports the optimal use of antimicrobials, including appropriate dosing decisions, administration...

Full description

Saved in:
Bibliographic Details
Published inInfection & chemotherapy Vol. 54; no. 4; pp. 637 - 673
Main Authors Cheong, Hae Suk, Park, Kyung-Hwa, Kim, Hong Bin, Kim, Shin-Woo, Kim, Bongyoung, Moon, Chisook, Lee, Mi Suk, Yoon, Young Kyung, Jeong, Su Jin, Kim, Yong Chan, Eun, Byung Wook, Lee, Hyukmin, Shin, Ji-Yeon, Kim, Hyung-sook, Hwang, In Sun, Park, Choon-Seon, Kwon, Ki Tae
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 01.12.2022
대한감염학회
Subjects
Review
내과학
Leadership
Accreditation
Antimicrobial resistance
Multidisciplinary
Financial support
Online AccessGet full text
ISSN2093-2340
2092-6448
DOI10.3947/ic.2022.0171

Cover

Abstract Currently, antimicrobial resistance (AMR) is a major threat to global public health. The antimicrobial stewardship program (ASP) has been proposed as an important approach to overcome this crisis. ASP supports the optimal use of antimicrobials, including appropriate dosing decisions, administration duration, and administration routes. In Korea, efforts are being made to overcome AMR using ASPs as a national policy. The current study aimed to develop core elements of ASP that could be introduced in domestic medical facilities. A Delphi survey was conducted twice to select the core elements through expert consensus. The core elements for implementing the ASP included (1) leadership commitment, (2) operating system, (3) action, (4) tracking, (5) reporting, and (6) education. To ensure these core elements are present at medical facilities, multiple departments must collaborate as teams for ASP operations. Establishing a reimbursement system and a workforce for ASPs are prerequisites for implementing ASPs. To ensure that ASP core elements are actively implemented in medical facilities, it is necessary to provide financial support for ASPs in medical facilities, nurture the healthcare workforce in performing ASPs, apply the core elements to healthcare accreditation, and provide incentives to medical facilities by quality evaluation criteria.
AbstractList Currently, antimicrobial resistance (AMR) is a major threat to global public health. The antimicrobial stewardship program (ASP) has been proposed as an important approach to overcome this crisis. ASP supports the optimal use of antimicrobials, including appropriate dosing decisions, administration duration, and administration routes. In Korea, efforts are being made to overcome AMR using ASPs as a national policy. The current study aimed to develop core elements of ASP that could be introduced in domestic medical facilities. A Delphi survey was conducted twice to select the core elements through expert consensus. The core elements for implementing the ASP included (1) leadership commitment, (2) operating system, (3) action, (4) tracking, (5) reporting, and (6) education. To ensure these core elements are present at medical facilities, multiple departments must collaborate as teams for ASP operations. Establishing a reimbursement system and a workforce for ASPs are prerequisites for implementing ASPs. To ensure that ASP core elements are actively implemented in medical facilities, it is necessary to provide financial support for ASPs in medical facilities, nurture the healthcare workforce in performing ASPs, apply the core elements to healthcare accreditation, and provide incentives to medical facilities by quality evaluation criteria. KCI Citation Count: 10
Currently, antimicrobial resistance (AMR) is a major threat to global public health. The antimicrobial stewardship program (ASP) has been proposed as an important approach to overcome this crisis. ASP supports the optimal use of antimicrobials, including appropriate dosing decisions, administration duration, and administration routes. In Korea, efforts are being made to overcome AMR using ASPs as a national policy. The current study aimed to develop core elements of ASP that could be introduced in domestic medical facilities. A Delphi survey was conducted twice to select the core elements through expert consensus. The core elements for implementing the ASP included (1) leadership commitment, (2) operating system, (3) action, (4) tracking, (5) reporting, and (6) education. To ensure these core elements are present at medical facilities, multiple departments must collaborate as teams for ASP operations. Establishing a reimbursement system and a workforce for ASPs are prerequisites for implementing ASPs. To ensure that ASP core elements are actively implemented in medical facilities, it is necessary to provide financial support for ASPs in medical facilities, nurture the healthcare workforce in performing ASPs, apply the core elements to healthcare accreditation, and provide incentives to medical facilities by quality evaluation criteria.
Currently, antimicrobial resistance (AMR) is a major threat to global public health. The antimicrobial stewardship program (ASP) has been proposed as an important approach to overcome this crisis. ASP supports the optimal use of antimicrobials, including appropriate dosing decisions, administration duration, and administration routes. In Korea, efforts are being made to overcome AMR using ASPs as a national policy. The current study aimed to develop core elements of ASP that could be introduced in domestic medical facilities. A Delphi survey was conducted twice to select the core elements through expert consensus. The core elements for implementing the ASP included (1) leadership commitment, (2) operating system, (3) action, (4) tracking, (5) reporting, and (6) education. To ensure these core elements are present at medical facilities, multiple departments must collaborate as teams for ASP operations. Establishing a reimbursement system and a workforce for ASPs are prerequisites for implementing ASPs. To ensure that ASP core elements are actively implemented in medical facilities, it is necessary to provide financial support for ASPs in medical facilities, nurture the healthcare workforce in performing ASPs, apply the core elements to healthcare accreditation, and provide incentives to medical facilities by quality evaluation criteria.Currently, antimicrobial resistance (AMR) is a major threat to global public health. The antimicrobial stewardship program (ASP) has been proposed as an important approach to overcome this crisis. ASP supports the optimal use of antimicrobials, including appropriate dosing decisions, administration duration, and administration routes. In Korea, efforts are being made to overcome AMR using ASPs as a national policy. The current study aimed to develop core elements of ASP that could be introduced in domestic medical facilities. A Delphi survey was conducted twice to select the core elements through expert consensus. The core elements for implementing the ASP included (1) leadership commitment, (2) operating system, (3) action, (4) tracking, (5) reporting, and (6) education. To ensure these core elements are present at medical facilities, multiple departments must collaborate as teams for ASP operations. Establishing a reimbursement system and a workforce for ASPs are prerequisites for implementing ASPs. To ensure that ASP core elements are actively implemented in medical facilities, it is necessary to provide financial support for ASPs in medical facilities, nurture the healthcare workforce in performing ASPs, apply the core elements to healthcare accreditation, and provide incentives to medical facilities by quality evaluation criteria.
Author Kim, Shin-Woo
Moon, Chisook
Yoon, Young Kyung
Kim, Bongyoung
Shin, Ji-Yeon
Park, Choon-Seon
Jeong, Su Jin
Cheong, Hae Suk
Hwang, In Sun
Kim, Hong Bin
Lee, Mi Suk
Lee, Hyukmin
Eun, Byung Wook
Kim, Yong Chan
Kim, Hyung-sook
Park, Kyung-Hwa
Kwon, Ki Tae
AuthorAffiliation 4 Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea
14 Korea Institute for Healthcare Accreditation, Seoul, Korea
1 Division of Infectious Diseases, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
6 Division of Infectious Diseases, Department of Internal Medicine, Inje University College of Medicine, Busan, Korea
11 Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea
5 Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea
9 Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
2 Department of Infectious Diseases, Chonnam National University Medical School, Gwangju, Korea
13 Department of Pharmacy, Seoul National University Bundang Hospital, Seongnam, Korea
16 Division of Infectious Diseases, Department of Internal Medicine, Kyungpook National University
AuthorAffiliation_xml – name: 7 Department of Internal Medicine, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul, Korea
– name: 6 Division of Infectious Diseases, Department of Internal Medicine, Inje University College of Medicine, Busan, Korea
– name: 12 Department of Preventive Medicine, School of Medicine, Kyungpook National University, Daegu, Korea
– name: 1 Division of Infectious Diseases, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
– name: 2 Department of Infectious Diseases, Chonnam National University Medical School, Gwangju, Korea
– name: 13 Department of Pharmacy, Seoul National University Bundang Hospital, Seongnam, Korea
– name: 11 Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea
– name: 10 Department of Pediatrics, Nowon Eulji University Hospital, Seoul, Korea
– name: 4 Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea
– name: 9 Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
– name: 5 Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea
– name: 14 Korea Institute for Healthcare Accreditation, Seoul, Korea
– name: 16 Division of Infectious Diseases, Department of Internal Medicine, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Korea
– name: 15 Health Insurance Review and Assessment Research Institute, Health Insurance Review and Assessment Service, Wonju, Korea
– name: 3 Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
– name: 8 Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
Author_xml – sequence: 1
  givenname: Hae Suk
  orcidid: 0000-0001-8702-1987
  surname: Cheong
  fullname: Cheong, Hae Suk
  organization: Division of Infectious Diseases, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
– sequence: 2
  givenname: Kyung-Hwa
  orcidid: 0000-0003-2836-6963
  surname: Park
  fullname: Park, Kyung-Hwa
  organization: Department of Infectious Diseases, Chonnam National University Medical School, Gwangju, Korea
– sequence: 3
  givenname: Hong Bin
  orcidid: 0000-0001-6262-372X
  surname: Kim
  fullname: Kim, Hong Bin
  organization: Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
– sequence: 4
  givenname: Shin-Woo
  orcidid: 0000-0002-3755-8249
  surname: Kim
  fullname: Kim, Shin-Woo
  organization: Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea
– sequence: 5
  givenname: Bongyoung
  orcidid: 0000-0002-5029-6597
  surname: Kim
  fullname: Kim, Bongyoung
  organization: Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea
– sequence: 6
  givenname: Chisook
  orcidid: 0000-0002-9063-9312
  surname: Moon
  fullname: Moon, Chisook
  organization: Division of Infectious Diseases, Department of Internal Medicine, Inje University College of Medicine, Busan, Korea
– sequence: 7
  givenname: Mi Suk
  orcidid: 0000-0001-8951-5032
  surname: Lee
  fullname: Lee, Mi Suk
  organization: Department of Internal Medicine, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul, Korea
– sequence: 8
  givenname: Young Kyung
  orcidid: 0000-0001-8435-935X
  surname: Yoon
  fullname: Yoon, Young Kyung
  organization: Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
– sequence: 9
  givenname: Su Jin
  orcidid: 0000-0003-4025-4542
  surname: Jeong
  fullname: Jeong, Su Jin
  organization: Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
– sequence: 10
  givenname: Yong Chan
  orcidid: 0000-0001-5081-7906
  surname: Kim
  fullname: Kim, Yong Chan
  organization: Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
– sequence: 11
  givenname: Byung Wook
  orcidid: 0000-0003-3147-9061
  surname: Eun
  fullname: Eun, Byung Wook
  organization: Department of Pediatrics, Nowon Eulji University Hospital, Seoul, Korea
– sequence: 12
  givenname: Hyukmin
  orcidid: 0000-0002-8523-4126
  surname: Lee
  fullname: Lee, Hyukmin
  organization: Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea
– sequence: 13
  givenname: Ji-Yeon
  orcidid: 0000-0001-5434-0359
  surname: Shin
  fullname: Shin, Ji-Yeon
  organization: Department of Preventive Medicine, School of Medicine, Kyungpook National University, Daegu, Korea
– sequence: 14
  givenname: Hyung-sook
  orcidid: 0000-0002-6385-9619
  surname: Kim
  fullname: Kim, Hyung-sook
  organization: Department of Pharmacy, Seoul National University Bundang Hospital, Seongnam, Korea
– sequence: 15
  givenname: In Sun
  orcidid: 0000-0003-1965-615X
  surname: Hwang
  fullname: Hwang, In Sun
  organization: Korea Institute for Healthcare Accreditation, Seoul, Korea
– sequence: 16
  givenname: Choon-Seon
  orcidid: 0000-0001-8298-0150
  surname: Park
  fullname: Park, Choon-Seon
  organization: Health Insurance Review and Assessment Research Institute, Health Insurance Review and Assessment Service, Wonju, Korea
– sequence: 17
  givenname: Ki Tae
  orcidid: 0000-0003-4666-0672
  surname: Kwon
  fullname: Kwon, Ki Tae
  organization: Division of Infectious Diseases, Department of Internal Medicine, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36596679$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002919040$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNptUc9vFCEYJabG1tqbZzNHY5wVGAaYi8lmU9uNTWpsezSEAWaLnYEpzGr87_1mtzXVyOVBeO99P95LdBBicAi9JnhRNUx88GZBMaULTAR5ho4obmjJGZMHu3tV0orhQ3SS83cMR0pGGv4CHVa8bjgXzRH6torJFae9G1yYctHFVKyHcf_0YVMsAQZvUmy97ouryf3UyeZbPxZfUtwkPeTCh-IzmOhQnLngEtDOYx79pPv8Cj3vANzJAx6jm0-n16vz8uLybL1aXpQGGppKLgUTreWOdtbi1lJtSS2xbYlouaEdp4ZKa4y1GgsjnbGMy0pr4UBXw5zH6N3eN6RO3RmvovY73ER1l9Ty6_VaEUxwxSgB8sc9edy2g7MGJoWm1Zj8oNOvnfTvn-BvweiHaiTDTV2DwdsHgxTvty5PavDZuL7XwcVtVlRwLImo-Ux987TWnyKPAQCB7gmw4pyT65SBzU0-zqV9D12rOWjljZqDVnPQIHr_j-jR97_03434qtY
CitedBy_id crossref_primary_10_3904_kjim_2023_506
crossref_primary_10_3947_ic_2022_0169
crossref_primary_10_3947_ic_2023_0032
crossref_primary_10_1093_ofid_ofae236
crossref_primary_10_3346_jkms_2024_39_e157
crossref_primary_10_3390_antibiotics14030266
crossref_primary_10_3947_ic_2023_0028
crossref_primary_10_3904_kjim_2023_482
crossref_primary_10_3947_ic_2023_0107
crossref_primary_10_3346_jkms_2024_39_e189
crossref_primary_10_3390_ph17070854
crossref_primary_10_7759_cureus_49935
crossref_primary_10_12771_emj_2024_e34
crossref_primary_10_3346_jkms_2024_39_e172
crossref_primary_10_1093_jac_dkae199
crossref_primary_10_1186_s13756_023_01319_8
crossref_primary_10_3947_ic_2024_0013
Cites_doi 10.1093/jac/dkr253
10.3346/jkms.2022.37.e191
10.3947/ic.2020.52.1.19
10.1016/S0140-6736(09)61879-1
10.1016/S0140-6736(12)60608-4
10.1017/ice.2018.121
10.1093/cid/ciw353
10.1093/cid/ciu542
10.1136/bmj.l236
10.1093/cid/ciw118
10.1136/ejhpharm-2021-002914
10.1001/archinte.1988.00380090091022
10.1186/cc13157
10.1542/peds.112.2.363
10.1371/journal.pone.0099101
10.1093/cid/cir409
10.1093/cid/civ447
10.1080/14787210.2020.1705155
10.1093/ofid/ofw186
10.1016/j.jiac.2019.05.012
10.5694/j.1326-5377.1988.tb120797.x
10.1136/bmjopen-2020-048187
10.1086/595694
10.1186/s13054-020-03067-2
10.1093/jac/dkx267
10.1128/AAC.00825-16
10.1086/510393
10.4065/mcp.2011.0358
10.4103/jpi.jpi_77_17
10.1161/CIR.0000000000000296
10.1128/AAC.01334-18
10.3947/ic.2021.0139
10.2146/ajhp140381
10.1093/cid/ciy255
10.3201/eid1101.040272
10.1086/502278
10.1016/S0954-6111(98)90351-1
10.1093/ofid/ofz389
10.1093/cid/cix767
10.1016/j.jiac.2018.11.001
10.1007/s10096-012-1786-4
10.3947/ic.2021.0093
10.1186/s13756-020-00751-4
10.3389/fphar.2021.616503
10.1093/cid/cix1093
10.1001/jama.290.19.2588
10.1016/S0149-2918(03)90101-9
10.1093/ofid/ofy314
10.1016/j.ajic.2015.05.011
10.2146/ajhp110729
10.3904/kjm.2014.87.2.173
10.1186/s13756-022-01082-2
10.1111/1469-0691.12191
10.1378/chest.110.4.965
10.1093/cid/ciaa1831
10.5124/jkma.2022.65.8.498
10.3346/jkms.2020.35.e407
10.1128/AAC.00431-09
10.1371/journal.pone.0209580
10.1017/ice.2019.352
10.1016/j.amjmed.2003.07.005
10.1016/j.jgar.2022.03.021
10.1128/CMR.05041-11
10.1097/MD.0000000000013719
10.1017/ice.2016.82
10.1007/s15010-016-0885-z
10.1016/S1473-3099(17)30325-0
10.1056/NEJMoa1411162
10.1016/j.annepidem.2004.01.003
10.1002/phar.2268
10.1055/s-0039-1693498
10.1111/j.1469-0691.2009.03077.x
10.1086/656623
10.3947/ic.2017.49.1.31
10.1093/jac/dkg032
10.1093/cid/cit370
10.5116/ijme.5a11.8422
10.1093/cid/cir272
10.1017/ice.2021.393
10.1097/00003246-200106000-00003
10.1016/j.jamcollsurg.2005.11.010
10.1093/cid/cit498
10.1016/j.ajic.2019.04.175
10.1093/cid/ciz1042
10.2146/090087c
10.1186/2052-3211-7-10
10.3947/ic.2021.0098
10.1016/j.cmi.2018.07.005
10.1542/peds.108.4.e75
10.1097/INF.0000000000001245
10.1016/j.jhin.2019.09.003
10.1093/ofid/ofz104
10.1038/s41598-018-33201-8
10.1007/s00134-019-05871-z
10.3343/alm.2017.37.3.231
10.3947/ic.2022.0069
10.1590/0037-8682-0413-2020
10.1016/j.ajic.2020.07.038
10.1093/cid/ciaa326
10.1086/677624
10.1001/jama.2016.0275
10.1086/375818
10.1001/jama.285.22.2871
10.1016/j.jgar.2016.10.013
10.1017/ice.2020.1234
10.1001/archinte.164.15.1669
10.14192/kjicp.2021.26.2.70
10.1155/2012/150367
10.3947/ic.2015.47.2.111
10.1093/cid/ciy149
10.1016/j.mcna.2018.05.010
10.1016/j.medmal.2016.02.007
10.1093/cid/cix692
10.1017/ice.2018.188
10.1093/jac/dkr088
ContentType Journal Article
Copyright Copyright © 2022 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS.
Copyright © 2022 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS 2022 The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS
Copyright_xml – notice: Copyright © 2022 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS.
– notice: Copyright © 2022 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS 2022 The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS
CorporateAuthor Korean Society for Healthcare-associated Infection Control and Prevention
The Korean Society of Infectious Diseases
Korean Society of Pediatric Infectious Diseases, The Korean Society of Health-system Pharmacists
Korean Society for Antimicrobial Therapy
Korean Society of Infectious Diseases
CorporateAuthor_xml – name: Korean Society for Antimicrobial Therapy
– name: The Korean Society of Infectious Diseases
– name: Korean Society for Healthcare-associated Infection Control and Prevention
– name: Korean Society of Pediatric Infectious Diseases, The Korean Society of Health-system Pharmacists
– name: Korean Society of Infectious Diseases
DBID AAYXX
CITATION
NPM
7X8
5PM
ACYCR
DOI 10.3947/ic.2022.0171
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2092-6448
EndPage 673
ExternalDocumentID oai_kci_go_kr_ARTI_10103421
PMC9840955
36596679
10_3947_ic_2022_0171
Genre Journal Article
Review
GrantInformation_xml – fundername: Korea Disease Control and Prevention Agency
  grantid: 2021-10-030
– fundername: ;
  grantid: 2021-10-030
GroupedDBID ---
5-W
8JR
8XY
9ZL
AAYXX
ABDBF
ACUHS
ACYCR
ADBBV
ADRAZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
C~G
DIK
DYU
EBD
EF.
GROUPED_DOAJ
HYE
KQ8
M48
M~E
OK1
PGMZT
RPM
NPM
7X8
5PM
ID FETCH-LOGICAL-c419t-68747bd6e2fdd0bd2ad1580db17b6c2f62c28dccdda07c8ecd4683aa7e7475093
IEDL.DBID M48
ISSN 2093-2340
IngestDate Fri May 30 10:58:52 EDT 2025
Thu Aug 21 18:38:32 EDT 2025
Fri Jul 11 03:00:41 EDT 2025
Thu Jan 02 22:54:13 EST 2025
Thu Apr 24 23:06:10 EDT 2025
Tue Jul 01 03:31:27 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Leadership
Accreditation
Antimicrobial resistance
Multidisciplinary
Financial support
Language English
License Copyright © 2022 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c419t-68747bd6e2fdd0bd2ad1580db17b6c2f62c28dccdda07c8ecd4683aa7e7475093
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
These authors contributed equally to this work as first authors.
https://www.icjournal.org/DOIx.php?id=10.3947/ic.2022.0171
ORCID 0000-0001-8298-0150
0000-0003-2836-6963
0000-0002-3755-8249
0000-0001-8951-5032
0000-0001-8435-935X
0000-0002-6385-9619
0000-0001-8702-1987
0000-0002-8523-4126
0000-0003-4666-0672
0000-0001-6262-372X
0000-0001-5081-7906
0000-0003-4025-4542
0000-0001-5434-0359
0000-0002-5029-6597
0000-0002-9063-9312
0000-0003-1965-615X
0000-0003-3147-9061
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3947/ic.2022.0171
PMID 36596679
PQID 2760817565
PQPubID 23479
PageCount 37
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_10103421
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9840955
proquest_miscellaneous_2760817565
pubmed_primary_36596679
crossref_citationtrail_10_3947_ic_2022_0171
crossref_primary_10_3947_ic_2022_0171
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-12-01
PublicationDateYYYYMMDD 2022-12-01
PublicationDate_xml – month: 12
  year: 2022
  text: 2022-12-01
  day: 01
PublicationDecade 2020
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Infection & chemotherapy
PublicationTitleAlternate Infect Chemother
PublicationYear 2022
Publisher The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS
대한감염학회
Publisher_xml – name: The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS
– name: 대한감염학회
References Regev-Yochay (10.3947/ic.2022.0171_ref130) 2011; 53
10.3947/ic.2022.0171_ref21
10.3947/ic.2022.0171_ref20
Lee (10.3947/ic.2022.0171_ref120) 2018; 23
Haas (10.3947/ic.2022.0171_ref52) 2016; 3
Park (10.3947/ic.2022.0171_ref4) 2022; 29
Seok (10.3947/ic.2022.0171_ref38) 2020; 52
Kim (10.3947/ic.2022.0171_ref102) 2018; 13
Peiffer-Smadja (10.3947/ic.2022.0171_ref77) 2020; 24
McNulty (10.3947/ic.2022.0171_ref82) 2011; 66
Chastre (10.3947/ic.2022.0171_ref60) 2003; 290
Kallen (10.3947/ic.2022.0171_ref110) 2009; 30
Yoon (10.3947/ic.2022.0171_ref68) 2014; 9
Zequinão (10.3947/ic.2022.0171_ref69) 2020; 53
Briceland (10.3947/ic.2022.0171_ref43) 1988; 148
Patel (10.3947/ic.2022.0171_ref88) 2012; 69
Weiss (10.3947/ic.2022.0171_ref129) 2011; 53
Cisneros (10.3947/ic.2022.0171_ref103) 2014; 20
Kim (10.3947/ic.2022.0171_ref135) 2022; 11
10.3947/ic.2022.0171_ref11
10.3947/ic.2022.0171_ref99
Carratalà (10.3947/ic.2022.0171_ref67) 2012; 172
10.3947/ic.2022.0171_ref98
Kim (10.3947/ic.2022.0171_ref134) 2020; 104
Al-Omari (10.3947/ic.2022.0171_ref115) 2020; 9
Bantar (10.3947/ic.2022.0171_ref44) 2003; 37
Moradi (10.3947/ic.2022.0171_ref86) 2020; 71
Langford (10.3947/ic.2022.0171_ref22) 2018; 39
McDonald (10.3947/ic.2022.0171_ref111) 2018; 66
Ji (10.3947/ic.2022.0171_ref31) 2021; 12
Dellit (10.3947/ic.2022.0171_ref124) 2007; 44
Tamma (10.3947/ic.2022.0171_ref58) 2012; 25
Heil (10.3947/ic.2022.0171_ref32) 2016; 37
Srinivas (10.3947/ic.2022.0171_ref76) 2019; 39
Garcia Reeves (10.3947/ic.2022.0171_ref131) 2020; 41
Choi (10.3947/ic.2022.0171_ref5) 2021; 14
Park (10.3947/ic.2022.0171_ref74) 2021; 53
Prkno (10.3947/ic.2022.0171_ref84) 2013; 17
Tacconelli (10.3947/ic.2022.0171_ref100) 2009; 53
10.3947/ic.2022.0171_ref122
Omidvari (10.3947/ic.2022.0171_ref65) 1998; 92
10.3947/ic.2022.0171_ref123
Song (10.3947/ic.2022.0171_ref41) 2015; 47
Hwang (10.3947/ic.2022.0171_ref105) 2018; 8
Tan (10.3947/ic.2022.0171_ref81) 2003; 51
Patel (10.3947/ic.2022.0171_ref119) 2012; 2012
De Waele (10.3947/ic.2022.0171_ref42) 2020; 46
Kim (10.3947/ic.2022.0171_ref96) 2022; 37
Meeker (10.3947/ic.2022.0171_ref117) 2016; 315
Doernberg (10.3947/ic.2022.0171_ref25) 2018; 67
Park (10.3947/ic.2022.0171_ref116) 2017; 49
Fralick (10.3947/ic.2022.0171_ref90) 2017; 8
Chotiprasitsakul (10.3947/ic.2022.0171_ref64) 2018; 66
Ibrahim (10.3947/ic.2022.0171_ref47) 2001; 29
Kim (10.3947/ic.2022.0171_ref101) 2018; 97
Kim (10.3947/ic.2022.0171_ref107) 2020; 35
Fukuda (10.3947/ic.2022.0171_ref34) 2014; 7
Fridkin (10.3947/ic.2022.0171_ref1) 2014; 63
Voiriot (10.3947/ic.2022.0171_ref85) 2021; 11
Hauck (10.3947/ic.2022.0171_ref48) 2004; 14
Bonner (10.3947/ic.2022.0171_ref75) 2003; 112
Bukowski (10.3947/ic.2022.0171_ref78) 2018; 62
Kim (10.3947/ic.2022.0171_ref39) 2014; 87
Owens (10.3947/ic.2022.0171_ref106) 2009; 66
Cunha (10.3947/ic.2022.0171_ref14) 2018; 102
Banerjee (10.3947/ic.2022.0171_ref73) 2015; 61
Apisarnthanarak (10.3947/ic.2022.0171_ref37) 2018; 39
Park (10.3947/ic.2022.0171_ref30) 2020; 41
Kalil (10.3947/ic.2022.0171_ref55) 2016; 63
Coupat (10.3947/ic.2022.0171_ref80) 2013; 32
Apisarnthanarak (10.3947/ic.2022.0171_ref35) 2015; 43
Honda (10.3947/ic.2022.0171_ref113) 2018; 5
Molina (10.3947/ic.2022.0171_ref104) 2017; 65
Hepburn (10.3947/ic.2022.0171_ref61) 2004; 164
Harbarth (10.3947/ic.2022.0171_ref54) 2003; 115
Choi (10.3947/ic.2022.0171_ref49) 2022; 54
Coates (10.3947/ic.2022.0171_ref57) 2020; 18
Talpaert (10.3947/ic.2022.0171_ref108) 2011; 66
Baur (10.3947/ic.2022.0171_ref12) 2017; 17
Maeda (10.3947/ic.2022.0171_ref29) 2019; 25
McCollum (10.3947/ic.2022.0171_ref70) 2003; 25
Yoon (10.3947/ic.2022.0171_ref15) 2021; 53
Abbo (10.3947/ic.2022.0171_ref46) 2013; 57
Kim (10.3947/ic.2022.0171_ref121) 2017; 37
Kim (10.3947/ic.2022.0171_ref112) 2021; 26
Price (10.3947/ic.2022.0171_ref109) 2010; 16
Karanika (10.3947/ic.2022.0171_ref13) 2016; 60
Williams (10.3947/ic.2022.0171_ref59) 2019; 40
Mahmood (10.3947/ic.2022.0171_ref36) 2022; 29
Yoo (10.3947/ic.2022.0171_ref132) 2022; 43
Hwang (10.3947/ic.2022.0171_ref6) 2021; 53
Davey (10.3947/ic.2022.0171_ref45) 2017; 2
Akazawa (10.3947/ic.2022.0171_ref114) 2019; 6
Sandberg (10.3947/ic.2022.0171_ref62) 2012; 380
Mullett (10.3947/ic.2022.0171_ref87) 2001; 108
Sawyer (10.3947/ic.2022.0171_ref63) 2015; 372
Siegel (10.3947/ic.2022.0171_ref66) 1996; 110
Waters (10.3947/ic.2022.0171_ref33) 2015; 72
Mediwala (10.3947/ic.2022.0171_ref53) 2019; 47
de With (10.3947/ic.2022.0171_ref26) 2016; 44
Bouadma (10.3947/ic.2022.0171_ref83) 2010; 375
Baddour (10.3947/ic.2022.0171_ref56) 2015; 132
Dellit (10.3947/ic.2022.0171_ref23) 2007; 44
Patterson (10.3947/ic.2022.0171_ref51) 2020; 48
Hoff (10.3947/ic.2022.0171_ref91) 2018; 9
Hurst (10.3947/ic.2022.0171_ref19) 2016; 35
Mehta (10.3947/ic.2022.0171_ref40) 2014; 35
Bochicchio (10.3947/ic.2022.0171_ref89) 2006; 202
Landgren (10.3947/ic.2022.0171_ref127) 1988; 149
O’Leary (10.3947/ic.2022.0171_ref97) 2020; 71
Le Coz (10.3947/ic.2022.0171_ref24) 2016; 46
Ten Oever (10.3947/ic.2022.0171_ref27) 2018; 24
Pollack (10.3947/ic.2022.0171_ref17) 2014; 59
Kiefe (10.3947/ic.2022.0171_ref118) 2001; 285
10.3947/ic.2022.0171_ref9
10.3947/ic.2022.0171_ref95
Barlam (10.3947/ic.2022.0171_ref7) 2016; 62
10.3947/ic.2022.0171_ref94
10.3947/ic.2022.0171_ref93
10.3947/ic.2022.0171_ref92
10.3947/ic.2022.0171_ref3
10.3947/ic.2022.0171_ref2
Gulliford (10.3947/ic.2022.0171_ref50) 2019; 364
Avdic (10.3947/ic.2022.0171_ref79) 2017; 72
Doron (10.3947/ic.2022.0171_ref128) 2011; 86
Ostrowsky (10.3947/ic.2022.0171_ref16) 2018; 66
Bauer (10.3947/ic.2022.0171_ref72) 2010; 51
Carling (10.3947/ic.2022.0171_ref126) 2003; 24
Belongia (10.3947/ic.2022.0171_ref125) 2005; 11
Nhan (10.3947/ic.2022.0171_ref18) 2019; 6
Madaras-Kelly (10.3947/ic.2022.0171_ref133) 2021; 73
Maeda (10.3947/ic.2022.0171_ref28) 2019; 25
Ryu (10.3947/ic.2022.0171_ref10) 2017; 8
Kwon (10.3947/ic.2022.0171_ref8) 2022; 65
Huang (10.3947/ic.2022.0171_ref71) 2013; 57
References_xml – volume: 66
  start-page: 2168
  year: 2011
  ident: 10.3947/ic.2022.0171_ref108
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkr253
– volume: 37
  start-page: e191
  year: 2022
  ident: 10.3947/ic.2022.0171_ref96
  publication-title: J Korean Med Sci
  doi: 10.3346/jkms.2022.37.e191
– volume: 52
  start-page: 19
  year: 2020
  ident: 10.3947/ic.2022.0171_ref38
  publication-title: Infect Chemother
  doi: 10.3947/ic.2020.52.1.19
– volume: 375
  start-page: 463
  year: 2010
  ident: 10.3947/ic.2022.0171_ref83
  publication-title: Lancet
  doi: 10.1016/S0140-6736(09)61879-1
– volume: 380
  start-page: 484
  year: 2012
  ident: 10.3947/ic.2022.0171_ref62
  publication-title: Lancet
  doi: 10.1016/S0140-6736(12)60608-4
– volume: 39
  start-page: 941
  year: 2018
  ident: 10.3947/ic.2022.0171_ref22
  publication-title: Infect Control Hosp Epidemiol
  doi: 10.1017/ice.2018.121
– ident: 10.3947/ic.2022.0171_ref94
– ident: 10.3947/ic.2022.0171_ref3
– volume: 63
  start-page: e61
  year: 2016
  ident: 10.3947/ic.2022.0171_ref55
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciw353
– ident: 10.3947/ic.2022.0171_ref123
– volume: 59
  start-page: S97
  issue: Suppl 3
  year: 2014
  ident: 10.3947/ic.2022.0171_ref17
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciu542
– volume: 364
  start-page: l236
  year: 2019
  ident: 10.3947/ic.2022.0171_ref50
  publication-title: BMJ
  doi: 10.1136/bmj.l236
– volume: 62
  start-page: e51
  year: 2016
  ident: 10.3947/ic.2022.0171_ref7
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciw118
– volume: 29
  start-page: 2
  year: 2022
  ident: 10.3947/ic.2022.0171_ref36
  publication-title: Eur J Hosp Pharm
  doi: 10.1136/ejhpharm-2021-002914
– volume: 148
  start-page: 2019
  year: 1988
  ident: 10.3947/ic.2022.0171_ref43
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.1988.00380090091022
– volume: 17
  start-page: R291
  year: 2013
  ident: 10.3947/ic.2022.0171_ref84
  publication-title: Crit Care
  doi: 10.1186/cc13157
– volume: 112
  start-page: 363
  year: 2003
  ident: 10.3947/ic.2022.0171_ref75
  publication-title: Pediatrics
  doi: 10.1542/peds.112.2.363
– volume: 9
  start-page: e99101
  year: 2014
  ident: 10.3947/ic.2022.0171_ref68
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0099101
– volume: 53
  start-page: 433
  year: 2011
  ident: 10.3947/ic.2022.0171_ref129
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cir409
– volume: 61
  start-page: 1071
  year: 2015
  ident: 10.3947/ic.2022.0171_ref73
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/civ447
– ident: 10.3947/ic.2022.0171_ref9
– volume: 18
  start-page: 5
  year: 2020
  ident: 10.3947/ic.2022.0171_ref57
  publication-title: Expert Rev Anti Infect Ther
  doi: 10.1080/14787210.2020.1705155
– volume: 3
  start-page: ofw186
  year: 2016
  ident: 10.3947/ic.2022.0171_ref52
  publication-title: Open Forum Infect Dis
  doi: 10.1093/ofid/ofw186
– volume: 25
  start-page: 653
  year: 2019
  ident: 10.3947/ic.2022.0171_ref28
  publication-title: J Infect Chemother
  doi: 10.1016/j.jiac.2019.05.012
– volume: 149
  start-page: 595
  year: 1988
  ident: 10.3947/ic.2022.0171_ref127
  publication-title: Med J Aust
  doi: 10.5694/j.1326-5377.1988.tb120797.x
– volume: 11
  start-page: e048187
  year: 2021
  ident: 10.3947/ic.2022.0171_ref85
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2020-048187
– volume: 30
  start-page: 264
  year: 2009
  ident: 10.3947/ic.2022.0171_ref110
  publication-title: Infect Control Hosp Epidemiol
  doi: 10.1086/595694
– volume: 24
  start-page: 366
  year: 2020
  ident: 10.3947/ic.2022.0171_ref77
  publication-title: Crit Care
  doi: 10.1186/s13054-020-03067-2
– volume: 72
  start-page: 3191
  year: 2017
  ident: 10.3947/ic.2022.0171_ref79
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkx267
– ident: 10.3947/ic.2022.0171_ref11
– volume: 60
  start-page: 4840
  year: 2016
  ident: 10.3947/ic.2022.0171_ref13
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.00825-16
– volume: 44
  start-page: 159
  year: 2007
  ident: 10.3947/ic.2022.0171_ref23
  publication-title: Clin Infect Dis
  doi: 10.1086/510393
– volume: 86
  start-page: 1113
  year: 2011
  ident: 10.3947/ic.2022.0171_ref128
  publication-title: Mayo Clin Proc
  doi: 10.4065/mcp.2011.0358
– volume: 9
  start-page: 10
  year: 2018
  ident: 10.3947/ic.2022.0171_ref91
  publication-title: J Pathol Inform
  doi: 10.4103/jpi.jpi_77_17
– volume: 132
  start-page: 1435
  year: 2015
  ident: 10.3947/ic.2022.0171_ref56
  publication-title: Circulation
  doi: 10.1161/CIR.0000000000000296
– volume: 62
  start-page: e01334
  year: 2018
  ident: 10.3947/ic.2022.0171_ref78
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.01334-18
– volume: 53
  start-page: 776
  year: 2021
  ident: 10.3947/ic.2022.0171_ref74
  publication-title: Infect Chemother
  doi: 10.3947/ic.2021.0139
– ident: 10.3947/ic.2022.0171_ref92
– volume: 72
  start-page: 466
  year: 2015
  ident: 10.3947/ic.2022.0171_ref33
  publication-title: Am J Health Syst Pharm
  doi: 10.2146/ajhp140381
– volume: 67
  start-page: 1168
  year: 2018
  ident: 10.3947/ic.2022.0171_ref25
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciy255
– volume: 11
  start-page: 912
  year: 2005
  ident: 10.3947/ic.2022.0171_ref125
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid1101.040272
– volume: 24
  start-page: 699
  year: 2003
  ident: 10.3947/ic.2022.0171_ref126
  publication-title: Infect Control Hosp Epidemiol
  doi: 10.1086/502278
– volume: 92
  start-page: 1032
  year: 1998
  ident: 10.3947/ic.2022.0171_ref65
  publication-title: Respir Med
  doi: 10.1016/S0954-6111(98)90351-1
– volume: 6
  start-page: ofz389
  year: 2019
  ident: 10.3947/ic.2022.0171_ref114
  publication-title: Open Forum Infect Dis
  doi: 10.1093/ofid/ofz389
– volume: 66
  start-page: 172
  year: 2018
  ident: 10.3947/ic.2022.0171_ref64
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cix767
– volume: 25
  start-page: 83
  year: 2019
  ident: 10.3947/ic.2022.0171_ref29
  publication-title: J Infect Chemother
  doi: 10.1016/j.jiac.2018.11.001
– volume: 32
  start-page: 627
  year: 2013
  ident: 10.3947/ic.2022.0171_ref80
  publication-title: Eur J Clin Microbiol Infect Dis
  doi: 10.1007/s10096-012-1786-4
– volume: 63
  start-page: 194
  year: 2014
  ident: 10.3947/ic.2022.0171_ref1
  publication-title: MMWR Morb Mortal Wkly Rep
– volume: 53
  start-page: 421
  year: 2021
  ident: 10.3947/ic.2022.0171_ref6
  publication-title: Infect Chemother
  doi: 10.3947/ic.2021.0093
– volume: 9
  start-page: 95
  year: 2020
  ident: 10.3947/ic.2022.0171_ref115
  publication-title: Antimicrob Resist Infect Control
  doi: 10.1186/s13756-020-00751-4
– volume: 14
  start-page: 3318
  year: 2021
  ident: 10.3947/ic.2022.0171_ref5
  publication-title: Pub Health Wkly Rep
– volume: 12
  start-page: 616503
  year: 2021
  ident: 10.3947/ic.2022.0171_ref31
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2021.616503
– volume: 66
  start-page: 995
  year: 2018
  ident: 10.3947/ic.2022.0171_ref16
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cix1093
– volume: 290
  start-page: 2588
  year: 2003
  ident: 10.3947/ic.2022.0171_ref60
  publication-title: JAMA
  doi: 10.1001/jama.290.19.2588
– volume: 25
  start-page: 3173
  year: 2003
  ident: 10.3947/ic.2022.0171_ref70
  publication-title: Clin Ther
  doi: 10.1016/S0149-2918(03)90101-9
– volume: 5
  start-page: ofy314
  year: 2018
  ident: 10.3947/ic.2022.0171_ref113
  publication-title: Open Forum Infect Dis
  doi: 10.1093/ofid/ofy314
– volume: 43
  start-page: 956
  year: 2015
  ident: 10.3947/ic.2022.0171_ref35
  publication-title: Am J Infect Control
  doi: 10.1016/j.ajic.2015.05.011
– volume: 2
  start-page: CD003543
  year: 2017
  ident: 10.3947/ic.2022.0171_ref45
  publication-title: Cochrane Database Syst Rev
– ident: 10.3947/ic.2022.0171_ref95
– ident: 10.3947/ic.2022.0171_ref122
– volume: 69
  start-page: 1543
  year: 2012
  ident: 10.3947/ic.2022.0171_ref88
  publication-title: Am J Health Syst Pharm
  doi: 10.2146/ajhp110729
– volume: 87
  start-page: 173
  year: 2014
  ident: 10.3947/ic.2022.0171_ref39
  publication-title: Korean J Med
  doi: 10.3904/kjm.2014.87.2.173
– volume: 11
  start-page: 40
  year: 2022
  ident: 10.3947/ic.2022.0171_ref135
  publication-title: Antimicrob Resist Infect Control
  doi: 10.1186/s13756-022-01082-2
– volume: 20
  start-page: 82
  year: 2014
  ident: 10.3947/ic.2022.0171_ref103
  publication-title: Clin Microbiol Infect
  doi: 10.1111/1469-0691.12191
– volume: 110
  start-page: 965
  year: 1996
  ident: 10.3947/ic.2022.0171_ref66
  publication-title: Chest
  doi: 10.1378/chest.110.4.965
– volume: 73
  start-page: e1126
  year: 2021
  ident: 10.3947/ic.2022.0171_ref133
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciaa1831
– volume: 65
  start-page: 498
  year: 2022
  ident: 10.3947/ic.2022.0171_ref8
  publication-title: J Korean Med Assoc
  doi: 10.5124/jkma.2022.65.8.498
– volume: 35
  start-page: e407
  year: 2020
  ident: 10.3947/ic.2022.0171_ref107
  publication-title: J Korean Med Sci
  doi: 10.3346/jkms.2020.35.e407
– volume: 53
  start-page: 4264
  year: 2009
  ident: 10.3947/ic.2022.0171_ref100
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.00431-09
– volume: 13
  start-page: e0209580
  year: 2018
  ident: 10.3947/ic.2022.0171_ref102
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0209580
– volume: 41
  start-page: 430
  year: 2020
  ident: 10.3947/ic.2022.0171_ref131
  publication-title: Infect Control Hosp Epidemiol
  doi: 10.1017/ice.2019.352
– volume: 115
  start-page: 529
  year: 2003
  ident: 10.3947/ic.2022.0171_ref54
  publication-title: Am J Med
  doi: 10.1016/j.amjmed.2003.07.005
– volume: 29
  start-page: 253
  year: 2022
  ident: 10.3947/ic.2022.0171_ref4
  publication-title: J Glob Antimicrob Resist
  doi: 10.1016/j.jgar.2022.03.021
– volume: 25
  start-page: 450
  year: 2012
  ident: 10.3947/ic.2022.0171_ref58
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.05041-11
– volume: 97
  start-page: e13719
  year: 2018
  ident: 10.3947/ic.2022.0171_ref101
  publication-title: Medicine (Baltimore)
  doi: 10.1097/MD.0000000000013719
– volume: 37
  start-page: 753
  year: 2016
  ident: 10.3947/ic.2022.0171_ref32
  publication-title: Infect Control Hosp Epidemiol
  doi: 10.1017/ice.2016.82
– volume: 44
  start-page: 395
  year: 2016
  ident: 10.3947/ic.2022.0171_ref26
  publication-title: Infection
  doi: 10.1007/s15010-016-0885-z
– volume: 17
  start-page: 990
  year: 2017
  ident: 10.3947/ic.2022.0171_ref12
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(17)30325-0
– volume: 372
  start-page: 1996
  year: 2015
  ident: 10.3947/ic.2022.0171_ref63
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1411162
– volume: 14
  start-page: 669
  year: 2004
  ident: 10.3947/ic.2022.0171_ref48
  publication-title: Ann Epidemiol
  doi: 10.1016/j.annepidem.2004.01.003
– ident: 10.3947/ic.2022.0171_ref98
– volume: 39
  start-page: 709
  year: 2019
  ident: 10.3947/ic.2022.0171_ref76
  publication-title: Pharmacotherapy
  doi: 10.1002/phar.2268
– volume: 40
  start-page: 476
  year: 2019
  ident: 10.3947/ic.2022.0171_ref59
  publication-title: Semin Respir Crit Care Med
  doi: 10.1055/s-0039-1693498
– volume: 16
  start-page: 1297
  year: 2010
  ident: 10.3947/ic.2022.0171_ref109
  publication-title: Clin Microbiol Infect
  doi: 10.1111/j.1469-0691.2009.03077.x
– volume: 172
  start-page: 922
  year: 2012
  ident: 10.3947/ic.2022.0171_ref67
  publication-title: Arch Intern Med
– ident: 10.3947/ic.2022.0171_ref93
– ident: 10.3947/ic.2022.0171_ref2
– volume: 51
  start-page: 1074
  year: 2010
  ident: 10.3947/ic.2022.0171_ref72
  publication-title: Clin Infect Dis
  doi: 10.1086/656623
– volume: 49
  start-page: 31
  year: 2017
  ident: 10.3947/ic.2022.0171_ref116
  publication-title: Infect Chemother
  doi: 10.3947/ic.2017.49.1.31
– volume: 51
  start-page: 379
  year: 2003
  ident: 10.3947/ic.2022.0171_ref81
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkg032
– volume: 57
  start-page: 631
  year: 2013
  ident: 10.3947/ic.2022.0171_ref46
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cit370
– ident: 10.3947/ic.2022.0171_ref20
– volume: 8
  start-page: 416
  year: 2017
  ident: 10.3947/ic.2022.0171_ref90
  publication-title: Int J Med Educ
  doi: 10.5116/ijme.5a11.8422
– volume: 53
  start-page: 33
  year: 2011
  ident: 10.3947/ic.2022.0171_ref130
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cir272
– volume: 43
  start-page: 1389
  year: 2022
  ident: 10.3947/ic.2022.0171_ref132
  publication-title: Infect Control Hosp Epidemiol
  doi: 10.1017/ice.2021.393
– volume: 29
  start-page: 1109
  year: 2001
  ident: 10.3947/ic.2022.0171_ref47
  publication-title: Crit Care Med
  doi: 10.1097/00003246-200106000-00003
– volume: 202
  start-page: 459
  year: 2006
  ident: 10.3947/ic.2022.0171_ref89
  publication-title: J Am Coll Surg
  doi: 10.1016/j.jamcollsurg.2005.11.010
– volume: 57
  start-page: 1237
  year: 2013
  ident: 10.3947/ic.2022.0171_ref71
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cit498
– volume: 23
  start-page: 1700734
  year: 2018
  ident: 10.3947/ic.2022.0171_ref120
  publication-title: Euro Surveill
– volume: 47
  start-page: 1284
  year: 2019
  ident: 10.3947/ic.2022.0171_ref53
  publication-title: Am J Infect Control
  doi: 10.1016/j.ajic.2019.04.175
– volume: 71
  start-page: 1684
  year: 2020
  ident: 10.3947/ic.2022.0171_ref86
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciz1042
– volume: 66
  start-page: S15
  issue: 12 Suppl 4
  year: 2009
  ident: 10.3947/ic.2022.0171_ref106
  publication-title: Am J Health Syst Pharm
  doi: 10.2146/090087c
– volume: 7
  start-page: 10
  year: 2014
  ident: 10.3947/ic.2022.0171_ref34
  publication-title: J Pharm Policy Pract
  doi: 10.1186/2052-3211-7-10
– volume: 53
  start-page: 617
  year: 2021
  ident: 10.3947/ic.2022.0171_ref15
  publication-title: Infect Chemother
  doi: 10.3947/ic.2021.0098
– volume: 24
  start-page: 1273
  year: 2018
  ident: 10.3947/ic.2022.0171_ref27
  publication-title: Clin Microbiol Infect
  doi: 10.1016/j.cmi.2018.07.005
– volume: 108
  start-page: E75
  year: 2001
  ident: 10.3947/ic.2022.0171_ref87
  publication-title: Pediatrics
  doi: 10.1542/peds.108.4.e75
– ident: 10.3947/ic.2022.0171_ref99
– volume: 35
  start-page: 1104
  year: 2016
  ident: 10.3947/ic.2022.0171_ref19
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/INF.0000000000001245
– volume: 104
  start-page: 172
  year: 2020
  ident: 10.3947/ic.2022.0171_ref134
  publication-title: J Hosp Infect
  doi: 10.1016/j.jhin.2019.09.003
– volume: 6
  start-page: ofz104
  year: 2019
  ident: 10.3947/ic.2022.0171_ref18
  publication-title: Open Forum Infect Dis
  doi: 10.1093/ofid/ofz104
– volume: 8
  start-page: 14757
  year: 2018
  ident: 10.3947/ic.2022.0171_ref105
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-33201-8
– volume: 46
  start-page: 236
  year: 2020
  ident: 10.3947/ic.2022.0171_ref42
  publication-title: Intensive Care Med
  doi: 10.1007/s00134-019-05871-z
– volume: 37
  start-page: 231
  year: 2017
  ident: 10.3947/ic.2022.0171_ref121
  publication-title: Ann Lab Med
  doi: 10.3343/alm.2017.37.3.231
– ident: 10.3947/ic.2022.0171_ref21
– volume: 54
  start-page: 340
  year: 2022
  ident: 10.3947/ic.2022.0171_ref49
  publication-title: Infect Chemother
  doi: 10.3947/ic.2022.0069
– volume: 53
  start-page: e20200413
  year: 2020
  ident: 10.3947/ic.2022.0171_ref69
  publication-title: Rev Soc Bras Med Trop
  doi: 10.1590/0037-8682-0413-2020
– volume: 48
  start-page: 1537
  year: 2020
  ident: 10.3947/ic.2022.0171_ref51
  publication-title: Am J Infect Control
  doi: 10.1016/j.ajic.2020.07.038
– volume: 71
  start-page: e702
  year: 2020
  ident: 10.3947/ic.2022.0171_ref97
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciaa326
– volume: 44
  start-page: 159
  year: 2007
  ident: 10.3947/ic.2022.0171_ref124
  publication-title: Clin Infect Dis
  doi: 10.1086/510393
– volume: 35
  start-page: 1092
  year: 2014
  ident: 10.3947/ic.2022.0171_ref40
  publication-title: Infect Control Hosp Epidemiol
  doi: 10.1086/677624
– volume: 315
  start-page: 562
  year: 2016
  ident: 10.3947/ic.2022.0171_ref117
  publication-title: JAMA
  doi: 10.1001/jama.2016.0275
– volume: 37
  start-page: 180
  year: 2003
  ident: 10.3947/ic.2022.0171_ref44
  publication-title: Clin Infect Dis
  doi: 10.1086/375818
– volume: 285
  start-page: 2871
  year: 2001
  ident: 10.3947/ic.2022.0171_ref118
  publication-title: JAMA
  doi: 10.1001/jama.285.22.2871
– volume: 8
  start-page: 70
  year: 2017
  ident: 10.3947/ic.2022.0171_ref10
  publication-title: J Glob Antimicrob Resist
  doi: 10.1016/j.jgar.2016.10.013
– volume: 41
  start-page: 1429
  year: 2020
  ident: 10.3947/ic.2022.0171_ref30
  publication-title: Infect Control Hosp Epidemiol
  doi: 10.1017/ice.2020.1234
– volume: 164
  start-page: 1669
  year: 2004
  ident: 10.3947/ic.2022.0171_ref61
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.164.15.1669
– volume: 26
  start-page: 70
  year: 2021
  ident: 10.3947/ic.2022.0171_ref112
  publication-title: Korean J healthc assoc Infect Control Prev
  doi: 10.14192/kjicp.2021.26.2.70
– volume: 2012
  start-page: 150367
  year: 2012
  ident: 10.3947/ic.2022.0171_ref119
  publication-title: Interdiscip Perspect Infect Dis
  doi: 10.1155/2012/150367
– volume: 47
  start-page: 111
  year: 2015
  ident: 10.3947/ic.2022.0171_ref41
  publication-title: Infect Chemother
  doi: 10.3947/ic.2015.47.2.111
– volume: 66
  start-page: 987
  year: 2018
  ident: 10.3947/ic.2022.0171_ref111
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciy149
– volume: 102
  start-page: 937
  year: 2018
  ident: 10.3947/ic.2022.0171_ref14
  publication-title: Med Clin North Am
  doi: 10.1016/j.mcna.2018.05.010
– volume: 46
  start-page: 200
  year: 2016
  ident: 10.3947/ic.2022.0171_ref24
  publication-title: Med Mal Infect
  doi: 10.1016/j.medmal.2016.02.007
– volume: 65
  start-page: 1992
  year: 2017
  ident: 10.3947/ic.2022.0171_ref104
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cix692
– volume: 39
  start-page: 1237
  year: 2018
  ident: 10.3947/ic.2022.0171_ref37
  publication-title: Infect Control Hosp Epidemiol
  doi: 10.1017/ice.2018.188
– volume: 66
  start-page: 1396
  year: 2011
  ident: 10.3947/ic.2022.0171_ref82
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkr088
SSID ssj0000884196
Score 2.340748
SecondaryResourceType review_article
Snippet Currently, antimicrobial resistance (AMR) is a major threat to global public health. The antimicrobial stewardship program (ASP) has been proposed as an...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 637
SubjectTerms Review
내과학
Title Core Elements for Implementing Antimicrobial Stewardship Programs in Korean General Hospitals
URI https://www.ncbi.nlm.nih.gov/pubmed/36596679
https://www.proquest.com/docview/2760817565
https://pubmed.ncbi.nlm.nih.gov/PMC9840955
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002919040
Volume 54
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Infection and Chemotherapy, 2022, 54(4), , pp.637-673
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1NT9wwELVgufSCikrL0nblCjihQOIktnNAFUIgPgSqBCvRQ2U5tgMR4IVkkeDfdybJrroUJC7xIeM4nokzb5zJG0LWAVEngqcuEJlMg4SnNsh5pIOksOAMY-TGxQ390zN-OEyOL9PLOTKpNtopsH41tMN6UsPqduvp4fknLPgdjDhhpO0SqQgZ20Lql3myAD5J4BI97YB-806WMomaYl0MQviAxUnYZsH_d4EZ_zTvq-I16Pkyg_Ifl3TwkSx2WJLutsZfInPOfyJ_9kaVo_ttVnhNAZPShgG4SQvyV3QXmruyoV-Cvue4d1ZZTNmiv9pUrZqWnp7ARbSnHSk1nVQXqZfJ8GD_Yu8w6GooBAYmPA64hHght9yxwtowt0zbKJWhzSORc8MKzgyT1hhrdSiMdMYmXMZaCwf9AEzEn0nPj7xbIRT_U5VWZ5kNNVZQB2AZF9xmLIcYNInCPtmcaE6ZjmAc61zcKgg0UM-qNAr1rFDPfbIxlb5viTXekFsDI6gbUypkwsb2aqRuKgV4_wgT1JDDEKR-TIykYH3gRw_t3eixVkxwQD0CcGuffGmNNh0v5ilEeyLrEzFjzqkAjjh7xpfXDQd3hoFxmq6-6-6-kg84nzYL5hvpjatH9x2wzDgfNHsAePw9HDSP7F8YqfLy
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Core+Elements+for+Implementing+Antimicrobial+Stewardship+Programs+in+Korean+General+Hospitals&rft.jtitle=Infection+%26+chemotherapy&rft.au=Cheong+Hae+Suk&rft.au=Park+Kyung-Hwa&rft.au=Kim+Hong+Bin&rft.au=%EA%B9%80%EC%8B%A0%EC%9A%B0&rft.date=2022-12-01&rft.pub=%EB%8C%80%ED%95%9C%EA%B0%90%EC%97%BC%ED%95%99%ED%9A%8C&rft.issn=2093-2340&rft.eissn=2092-6448&rft.spage=637&rft.epage=673&rft_id=info:doi/10.3947%2Fic.2022.0171&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_10103421
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2093-2340&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2093-2340&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2093-2340&client=summon